Morgan Stanley
ELOS

Morgan Stanley’s Syneron Medical Ltd ELOS Stock Holding History

Morgan Stanley’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-215,828
Closed -$2.36M – 6778
2017
Q2 		$2.36M Buy
215,828
+119,339
+124% +$1.31M ﹤0.01% 3657
2017
Q1 		$1.02M Buy
96,489
+65,794
+214% +$636K ﹤0.01% 4369
2016
Q4 		$257K Buy
30,695
+27,493
+859% +$215K ﹤0.01% 5251
2016
Q3 		$23K Sell
3,202
-1,035
-24% -$7.2K ﹤0.01% 5878
2016
Q2 		$32K Sell
4,237
-1,214
-22% -$8.65K ﹤0.01% 5691
2016
Q1 		$39K Buy
5,451
+205
+4% +$1.47K ﹤0.01% 5707
2015
Q4 		$40K Sell
5,246
-2,243
-30% -$17.1K ﹤0.01% 5794
2015
Q3 		$53K Sell
7,489
-13,723
-65% -$132K ﹤0.01% 5707
2015
Q2 		$225K Sell
21,212
-57,322
-73% -$671K ﹤0.01% 5182
2015
Q1 		$973K Buy
78,534
+57,650
+276% +$638K ﹤0.01% 4150
2014
Q4 		$195K Buy
20,884
+9,181
+78% +$88.5K ﹤0.01% 5250
2014
Q3 		$117K Sell
11,703
-5,461
-32% -$55.6K ﹤0.01% 5412
2014
Q2 		$177K Buy
17,164
+871
+5% +$9.41K ﹤0.01% 5227
2014
Q1 		$202K Buy
16,293
+3,630
+29% +$43K ﹤0.01% 5117
2013
Q4 		$155K Buy
+12,663
New +$132K ﹤0.01% 5148
2013
Q3 		– Sell
-18,115
Closed -$158K – 5446
2013
Q2 		$158K Buy
+18,115
New +$162K ﹤0.01% 4942

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Morgan Stanley's ELOS Position: Q3 2017 in Review

Morgan Stanley sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 215,828 shares — an estimated $2.36M sold.

Morgan Stanley first reported a position in ELOS in Q2 2013 and held it in 16 quarters. The position peaked at $2.36M in Q2 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • Morgan Stanley reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • Morgan Stanley sold 215,828 Syneron Medical Ltd shares in Q3 2017, an estimated $2.36M.
  • Morgan Stanley first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 16 quarters.
  • Morgan Stanley's Syneron Medical Ltd position peaked at $2.36M in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Morgan Stanley's 13F filing for Q3 2017, filed 14 Nov 2017.